Cancer Research  AM No Date
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakada, M.
Right arrow Articles by Sato, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakada, M.
Right arrow Articles by Sato, H.
[Cancer Research 63, 3364-3369, June 15, 2003]
© 2003 American Association for Cancer Research


Tumor Biology

Testican 2 Abrogates Inhibition of Membrane-type Matrix Metalloproteinases by Other Testican Family Proteins1

Mitsutoshi Nakada2, Hisashi Miyamori2, Junkoh Yamashita and Hiroshi Sato3

Department of Molecular Virology and Oncology [M. N., H. M., H. S.], Center for the Development of Molecular Target Drugs, Cancer Research Institute [H. S.], Department of Neurosurgery, Division of Neuroscience, Graduate School of Medical Science [M. N., J. Y.], Kanazawa University, Ishikawa 920-0934, Japan

Testican family proteins are putative extracellular heparan/chondroitin sulfate proteoglycans of unknown function. We identified recently N-Tes, which is a product of testican 3 splicing variant gene, as an inhibitor of membrane-type matrix metalloproteinases (MT-MMPs). The inhibitory function is common among testican family members except for testican 2, which was shown to uniquely abolish inhibition of MT1-MMP- or MT3-MMP-mediated pro-MMP-2 activation by other testican family members. Testican 2 inactivates N-Tes by binding to the COOH-terminal extracellular calcium-binding domain of N-Tes through its NH2-terminal unique domain as demonstrated by coimmunoprecipitation analysis, and, thus, testican 2 was unable to inactivate a N-Tes deletion mutant lacking the extracellular calcium-binding domain (N-Tes-{Delta}122). Migration of U251 cells on collagen, which was dependent on MT1-MMP activity under serum-free condition, was inhibited by N-Tes or N-Tes-{Delta}122 deposited on collagen. Testican 2 was not incorporated into collagen by itself, and was deposited only in the presence of N-Tes, suggesting that testican 2 binds to N-Tes deposited on collagen. Binding of testican 2 to N-Tes deposited on collagen allowed migration of cells expressing MT1-MMP. Unlike wild-type N-Tes, N-Tes-{Delta}122 did not bind to testican 2, and, thus, expression of testican 2 did not recover cell migration blocked by N-Tes-{Delta}122. In situ hybridization showed that neurons are a major source of all of the testican family members in the normal brain. The quantitative reverse transcription-PCR analysis demonstrated that all of the testican family members are expressed prominently in normal brain, and their expression levels decrease as tumor grade increases. The expression level of testican 2 was the highest among testican family members regardless of histological grade of astrocytic tumors. These results suggest that abundant distribution of testican 2 may contribute to glioma invasion by inactivating other testican family members including N-Tes, which all inhibit MT-MMPs. We propose that N-Tes-{Delta}122, which is resistant to testican 2, may have therapeutic potential as a barrier against glioma invasion.




This article has been cited by other articles:


Home page
Cereb CortexHome page
T. Takahata, Y. Komatsu, A. Watakabe, T. Hashikawa, S. Tochitani, and T. Yamamori
Differential Expression Patterns of occ1-Related Genes in Adult Monkey Visual Cortex
Cereb Cortex, December 10, 2008; (2008) bhn220v1.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Itoh, N. Ito, H. Nagase, and M. Seiki
The Second Dimer Interface of MT1-MMP, the Transmembrane Domain, Is Essential for ProMMP-2 Activation on the Cell Surface
J. Biol. Chem., May 9, 2008; 283(19): 13053 - 13062.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
O. J Sansom, F. C Mansergh, M. J Evans, J. A Wilkins, and A. R Clarke
Deficiency of SPARC suppresses intestinal tumorigenesis in APCMin/+ mice
Gut, October 1, 2007; 56(10): 1410 - 1414.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
M. Novinec, D. Kordis, V. Turk, and B. Lenarcic
Diversity and Evolution of the Thyroglobulin Type-1 Domain Superfamily
Mol. Biol. Evol., April 1, 2006; 23(4): 744 - 755.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Schnepp, P. K. Lindgren, H. Hulsmann, S. Kroger, M. Paulsson, and U. Hartmann
Mouse Testican-2: EXPRESSION, GLYCOSYLATION, AND EFFECTS ON NEURITE OUTGROWTH
J. Biol. Chem., March 25, 2005; 280(12): 11274 - 11280.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.